Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Analysis of Immunological Reactions to Foods in Birch Pollen-Allergic Patients
This study is not yet open for participant recruitment.
Verified by Medical University of Vienna, October 2008
Sponsored by: Medical University of Vienna
Information provided by: Medical University of Vienna
ClinicalTrials.gov Identifier: NCT00787631
  Purpose

A high number of birch pollen-allergic individuals develop hypersensitivity reactions to certain foods, e.g. apples. This food allergy is due to immunological cross-reactivity. Birch pollen-related foods contain proteins, e.g. Mal d 1 in apple, that are structurally related with the major birch pollen allergen, Bet v 1. Hence IgE antibodies and T lymphocytes specific for Bet v 1 recognize these food proteins which results in activation of the immune system and, consequently, in clinical symptoms.

In the present study the investigators intend to investigate if and how the consumption of birch pollen-related food allergens affects birch pollen allergy. In other words, the investigators are interested to analyse whether Bet v 1-related food allergens activate Bet v 1-specific memory cells and thus, contribute to the maintenance of the pollen allergy outside the pollen season. Data obtained in this study will help to clarify the immunological and clinical role of cross-reactivity between pollen and food allergies and will reveal whether avoidance of such foods should be recommended for the patients. Finally, novel approaches for diagnosis and therapy of pollen-related food allergens can be developed.


Condition
Allergic Rhinitis
Food Allergy

MedlinePlus related topics: Allergy Food Allergy Hay Fever
U.S. FDA Resources
Study Type: Observational
Study Design: Case-Only, Prospective
Official Title: Analysis of Immunological Reactions to Pollen-Related Foods in Birch Pollen-Allergic Patients

Further study details as provided by Medical University of Vienna:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 30
Study Start Date: December 2008
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

otherwise healthy birch pollen allergic (rhinoconjunctivitis)persons suffering also from oral allergy syndrome to apple.

Criteria

Inclusion Criteria:

  • Otherwise healthy birch pollen allergic (rhinoconjunctivitis)persons
  • Positive SPT and RAST to birch pollen
  • Sensitized to Bet v 1

Exclusion Criteria:

  • Persons suffering from malignancies, autoimmune and cardiopulmonary diseases
  • Anemia
  • Hyper-IgE syndrome
  • Treatment with ß-blockers, permanent treatment with antihistaminics, leucotriene antagonists, corticosteroids
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00787631

Contacts
Contact: Tamar Kinaciyan, Ass.Prof.MD +43140400 ext 7700 tamar.kinaciyan@meduniwien.ac.at
Contact: Barbara Bohle, AssocProf Dr +43140400 ext 5114 barbara.bohle@meduniwien.ac.at

Sponsors and Collaborators
Medical University of Vienna
Investigators
Principal Investigator: Tamar Kinaciyan, Ass Prof MD Dept. of Dermatology, Medical University of Vienna
  More Information

Responsible Party: DIAID, Dep. of Dermatology, MUV ( Tamar Kinaciyan, MD, Ass. Prof. )
Study ID Numbers: TK01/2008
Study First Received: October 23, 2008
Last Updated: November 6, 2008
ClinicalTrials.gov Identifier: NCT00787631  
Health Authority: Austria: Federal Office for Safety in Health Care

Keywords provided by Medical University of Vienna:
birch pollen pollen allergy
oral allergy syndrome to apple
cross reactivity
bet v 1
mal d 1

Study placed in the following topic categories:
Food Hypersensitivity
Hypersensitivity
Otorhinolaryngologic Diseases
Respiratory Tract Infections
Respiratory Tract Diseases
Rhinitis, Allergic, Seasonal
Hypersensitivity, Immediate
Rhinitis

Additional relevant MeSH terms:
Immune System Diseases
Nose Diseases

ClinicalTrials.gov processed this record on January 16, 2009